The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
about
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in miceLymphangiogenesis in Oral Squamous Cell Carcinoma: Correlation with VEGF-C Expression and Lymph Node Metastasis.Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanismOverexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancerDriving CAR T-cells forwardEndothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization.The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancer.Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits.Inhibition of BMP signaling suppresses metastasis in mammary cancerCompartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.The non-canonical role of vascular endothelial growth factor-C axis in cancer progressionTissue engineering and regeneration of lymphatic structures.Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions (Review).Inhibition of Vascular Endothelial Growth Factor Receptor 3 Reduces Migration of Gastric Cancer Cells.Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells.Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis.BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.The development of CAR design for tumor CAR-T cell therapy.VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
P2860
Q21131825-59B21606-D862-4DAF-B46A-B7050124BD93Q33819978-713FC41B-4539-4918-8B29-404ABBB7AEFDQ33850748-F41BC62A-793A-440D-B554-B9D16329281BQ33859145-BEEE7547-9357-4CD6-A3F4-87381D27C2F5Q34046505-8CEC2563-1AE2-468E-9645-BB90382591DCQ34311544-90ED07FA-7DE8-478E-A919-754383E3980EQ35658497-64CF4EDB-1404-4516-BF89-F02BFCF505DFQ36265146-08FFDAB3-8CD0-4656-898B-F99B9782FEDAQ36398681-DF4A49A3-D54C-4924-ACD0-024C4E7C9C39Q37054876-475F8CAA-1C40-471A-8ED8-BFBCF6007C7DQ37071029-8FDE0C74-FA84-4C9C-B844-B625C459C97EQ38131800-F4DFE48D-1720-4581-9DF1-4FF1F8957AFEQ38645097-52D9C921-F043-4FE7-968C-906D4D3E8F04Q38859740-FE893B73-D5C2-4C8E-A83B-99099B6E20D5Q42363709-E7A60EF3-F5F4-4B0D-B623-91F323CCC383Q49884430-DCA4886A-8648-4B7E-ACF2-C9ADDE6A1DE9Q51369579-A585DB43-8A42-4661-B624-AF64709285F9Q52641562-8FB7B1A4-DE37-4C9A-B37C-3F9C84AC55E8Q57291646-323F00C8-80A9-4D34-ACA0-593106A9FA0C
P2860
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
@ast
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
@en
type
label
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
@ast
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
@en
prefLabel
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
@ast
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
@en
P2093
P2860
P921
P356
P1476
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
@en
P2093
Chih-Chen Hong
Jen-Liang Su
Jui-Chieh Chen
Yang-Hao Yu
Yi-Wen Chang
P2860
P304
P356
10.3390/IJMS14010088
P407
P5008
P577
2012-12-20T00:00:00Z